{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:15:44Z","timestamp":1767150944517,"version":"build-2238731810"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2720,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/modpathol.2015.66","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T07:42:15Z","timestamp":1433490135000},"page":"1014-1022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies"],"prefix":"10.1016","volume":"28","author":[{"given":"C Cameron","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi K","family":"Shamanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tariq","family":"Muzzafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"DiNardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph D","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa A","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2015.66_bib1","series-title":"WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues","first-page":"88","article-title":"Myelodysplastic syndromes\/neoplasms, overview","author":"Brunning","year":"2008"},{"key":"10.1038\/modpathol.2015.66_bib2","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00277-009-0745-3","article-title":"Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS\/MPN category","volume":"88","author":"Bacher","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1038\/modpathol.2015.66_bib3","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/1097-0142(19920915)70:4+<1701::AID-CNCR2820701609>3.0.CO;2-S","article-title":"Cytogenetic analysis in the diagnosis of acute leukemia","volume":"70","author":"Heim","year":"1992","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2015.66_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/geno.1998.5231","article-title":"A detailed physical and transcriptional map of the region of chromosome 20 that is deleted in myeloproliferative disorders and refinement of the common deleted region","volume":"49","author":"Bench","year":"1998","journal-title":"Genomics"},{"key":"10.1038\/modpathol.2015.66_bib5","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.66_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2141.2007.06776.x","article-title":"Myelodysplastic syndrome with isolated deletion of chromosome 20q: an indolent disease with minimal morphological dysplasia and frequent thrombocytopenic presentation","volume":"139","author":"Gupta","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.2015.66_bib7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/leu.2010.234","article-title":"Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients","volume":"25","author":"Caramazza","year":"2011","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2015.66_bib8","first-page":"67","article-title":"The prognostic significance of deletion of the long arm of chromosome 20 in myeloid disorders","volume":"8","author":"Campbell","year":"1994","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2015.66_bib9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European Leukemia Net","volume":"115","author":"Dohner","year":"2010","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.66_bib10","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.leukres.2011.02.008","article-title":"Characteristics and outcome of myelodysplastic syndromes(MDS) with isolated 20q deletion: a report on 62 cases","volume":"35","author":"Braun","year":"2011","journal-title":"Leuk Res"},{"key":"10.1038\/modpathol.2015.66_bib11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/1042819031000063507","article-title":"Clinico-hematologic features of myelodysplastic syndrome presenting as isolated thrombocytopenia: an entity with a relatively favorable prognosis","volume":"44","author":"Sashida","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/modpathol.2015.66_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0145-2126(02)00161-3","article-title":"Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia?","volume":"27","author":"Steensma","year":"2003","journal-title":"Leuk Res"},{"key":"10.1038\/modpathol.2015.66_bib13","series-title":"WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues","first-page":"127","article-title":"Therapy-related myeloid neoplasms","author":"Vardiman","year":"2008"},{"key":"10.1038\/modpathol.2015.66_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/leu.2013.191","article-title":"Application of the international prognostic scoring system-revised in therapy-related myelodysplastic syndromesand oligoblastic acute myeloid leukemia","volume":"28","author":"Ok","year":"2014","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2015.66_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MOH.0b013e32835d82e6","article-title":"Recent advances in the management of therapy-related myelodysplastic syndromesand acute myeloid leukemia","volume":"20","author":"Klimek","year":"2013","journal-title":"Curr Opin Hematol"},{"key":"10.1038\/modpathol.2015.66_bib16","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1182\/blood.V86.9.3542.bloodjournal8693542","article-title":"Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia","volume":"86","author":"Pedersen-Bjergaard","year":"1995","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.66_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cancergen.2012.12.005","article-title":"Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q)","volume":"206","author":"Kanagal-Shamanna","year":"2013","journal-title":"Cancer Genet"},{"key":"10.1038\/modpathol.2015.66_bib18","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.leukres.2014.05.015","article-title":"Clinically silent clonal cytogenetic abnormalities arising in patients treated for lymphoid neoplasms","volume":"38","author":"Tang","year":"2014","journal-title":"Leuk Res"},{"key":"10.1038\/modpathol.2015.66_bib19","series-title":"Recommendations of the International Standing Commitee on Human Cytogenetic Nomenclature","first-page":"39","author":"Shaffer","year":"2013"},{"key":"10.1038\/modpathol.2015.66_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ajh.23380","article-title":"Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components","volume":"88","author":"Wang","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1038\/modpathol.2015.66_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cancergen.2014.02.002","article-title":"The characteristics and prognostic analysis in 213 myeloid malignancy patients with del(20q): a report of a single-center case series","volume":"207","author":"Pan","year":"2014","journal-title":"Cancer Genet"},{"key":"10.1038\/modpathol.2015.66_bib22","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.leukres.2011.01.003","article-title":"Clinical impact of the clone size in MDS cases with monosomy 7 or 7q deletion, trisomy 8, 20q deletion and loss of Y chromosome","volume":"35","author":"Mallo","year":"2011","journal-title":"Leuk Res"},{"key":"10.1038\/modpathol.2015.66_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cancergen.2011.12.002","article-title":"Microarray CGH analyses of chromosomal 20q deletions in patients with hematopoietic malignancies","volume":"205","author":"Okada","year":"2012","journal-title":"Cancer Genet"},{"key":"10.1038\/modpathol.2015.66_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/(SICI)1098-2264(199802)21:2<75::AID-GCC1>3.0.CO;2-4","article-title":"Refinement of the commonly deleted segment in myeloid leukemias with a del(20q)","volume":"21","author":"Wang","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/modpathol.2015.66_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0165-4608(94)00150-A","article-title":"Characterization of 20q deletions in patients with myeloproliferative disorders or myelodysplastic syndromes","volume":"80","author":"Nacheva","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1038\/modpathol.2015.66_bib26","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1038\/sj.onc.1203728","article-title":"Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC\/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG)","volume":"19","author":"Bench","year":"2000","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2015.66_bib27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/gcc.20748","article-title":"Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis","volume":"49","author":"Huh","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/modpathol.2015.66_bib28","doi-asserted-by":"crossref","first-page":"22552","DOI":"10.1073\/pnas.1017092108","article-title":"L3MBTL1 polycomb protein, a candidate tumor suppressor in del(20q12) myeloid disorders, is essential for genome stability","volume":"107","author":"Gurvich","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2015.66_bib29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.leukres.2014.11.005","article-title":"Isolated +15 in bone marrow: Disease-associated or a benign finding?","volume":"39","author":"Goswami","year":"2015","journal-title":"Leuk Res"},{"key":"10.1038\/modpathol.2015.66_bib30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2141.2008.07023.x","article-title":"Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphoma","volume":"141","author":"Basecke","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.2015.66_bib31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0165-4608(00)00236-3","article-title":"Nonclonal chromosomal aberrations induced by anti-tumoral regimens in childhood cancer: relationship with cancer-related genes and fragile sites","volume":"121","author":"Lopez de Mesa","year":"2000","journal-title":"Cancer Genet Cytogenet"}],"updated-by":[{"DOI":"10.1038\/modpathol.2016.76","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000}}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol201566.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201566","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222013849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222013849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201566.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T06:46:58Z","timestamp":1717915618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222013849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0893395222013849"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2015.66","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2015.66","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2016.76","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}